Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent

Julie K Horton1, Donna F Stefanick, Jana M Naron

  • 1Laboratory of Structural Biology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.

Insights

Inhibiting poly(ADP-ribose) polymerase (PARP) activity sensitizes cells to methyl methanesulfonate (MMS) by maintaining an ATR and Chk1-dependent S-phase checkpoint. This DNA repair pathway is crucial for cell survival after DNA damage.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • DNA Repair Mechanisms

Background:

  • Mouse fibroblasts deficient in DNA polymerase beta exhibit hypersensitivity to methyl methanesulfonate (MMS).
  • Poly(ADP-ribose) polymerase (PARP) inhibitors, like 4-amino-1,8-naphthalimide (4-AN), enhance the cytotoxic effects of MMS in both wild-type and repair-deficient cells.

Purpose of the Study:

  • To investigate the role of PARP inhibition in sensitizing cells to DNA methylating agents.
  • To elucidate the cell cycle and signaling pathways involved in the observed sensitization.

Main Methods:

  • Treatment of synchronized mouse fibroblasts with methyl methanesulfonate (MMS) and 4-amino-1,8-naphthalimide (4-AN).
  • Cell cycle analysis using flow cytometry.
  • Inhibition of checkpoint kinases ATM and ATR using caffeine.
  • Analysis of signaling pathway activation (Chk1) in cell extracts.

Main Results:

  • 4-AN treatment, particularly during S-phase, significantly sensitizes cells to MMS and 5-hydroxymethyl-2'-deoxyuridine.
  • Combined MMS and 4-AN treatment leads to complete inhibition of DNA synthesis and S-phase arrest, dependent on continuous 4-AN exposure.
  • Caffeine prevents sustained S-phase arrest, leading to G2/M arrest, and suppresses MMS/4-AN-induced Chk1 activation.

Conclusions:

  • Inhibition of PARP activity by 4-AN sensitizes cells to MMS by enforcing an S-phase checkpoint.
  • This checkpoint maintenance relies on the ATR and Chk1 signaling pathway.
  • PARP inhibition is a potential strategy to enhance the efficacy of DNA-damaging agents in cancer therapy.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...